Skip Navigation



Carcinogenesis Advance Access published online on December 4, 2003
Carcinogenesis, doi:10.1093/carcin/bgh037
© 2003 by Oxford University Press
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
25/4/631    most recent
bgh037v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Yeh, C.-N.
Right arrow Articles by Chen, M.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yeh, C.-N.
Right arrow Articles by Chen, M.-F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 Oxford University Press

CARCINOGENESIS

Thioacetamide-induced intestinal-type cholangiocarcinoma in rat

Chun-Nan Yeh 1*, Anirban Maitra 2, Kam-Fai Lee 3, Yi-Yin Jan 1, and Miin-Fu Chen 1

1 Department of Surgery, Chang Gung Memorial Hospital, Chang Gung University, Taiwan
2 Department of Pathology, Johns Hopkins University, Baltimore, USA
3 Department of Pathology, Chang Gung Memorial Hospital, Chang Gung University, Taiwan

* Corresponding author. E-mail: ycn{at}adm.cgmh.org.tw.

Received 18 September 2003 ; revised 17 November 2003 ; accepted 19 November 2003

Abstract

Background: Cholagiocarcinoma (CCA) is a lethal disease, afflicting many thousands the world over. Human CCA develops through a multistep progression model, preceded by the onset of dysplasia in the cholangiolar ductal epithelium. An animal model of multistep carcinogenesis in the biliary tree will enable the study of genetic changes in human CCA, and provide an avenue for chemoprevention strategies. We describe an oral thioacetamide (TAA) induced model of rat CCA that recapitulates the histologic progression of human CCA.

Methods: Male Sprague-Dawley (S-D) rats (n=170), weighing between 350±20g, were used in this study. Drinking water with TAA 300 mg/L was administered orally, and the liver was harvested and examined histologically at weekly intervals, beginning at 5 weeks after initiation of TAA. Harvested tissues were formalin-fixed and paraffin embedded for morphologic and immunohistochemical studies.

Results: Multifocal bile ductular proliferation with intestinal metaplasia (presence of goblet cells) and increasing histologic atypia (biliary dysplasia) was observed by the 9th week of TAA administration. Biliary cytokeratin (CK19)-expressing invasive intestinal-type CCA with stromal desmoplasia was evident at the 16th week, and by the 22nd week, the yield rate for CCAs had increased to 100%. Invasive CCAs preceded the development of hepatic cirrhosis by at least 4 weeks; the earliest incidence of hepatic fibrosis was observed beginning at 20 weeks post-TAA administration. The progression from normal cholangioles to biliary dysplasia to invasive CCA was accompanied by upregulation of the proto-oncogenes c-met and c-erbB-2, tyrosine kinase receptors overexpressed in human CCAs. The study was terminated at 6 months, at which time no systemic metastases or deaths were observed.

Conclusions: Oral administration of TAA in drinking water to male SD rats provides a reproducible animal model for development of CCA with a high yield rate. In particular, the presence of biliary dysplasia beginning at the 9th week, which progresses to invasive CCA, mimics the multistep model of human CCA. The TAA rat model may serve as a powerful pre-clinical platform for therapeutic and chemoprevention strategies for human CCA.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
G. Fava, G. Alpini, C. Rychlicki, S. Saccomanno, S. DeMorrow, L. Trozzi, C. Candelaresi, J. Venter, A. Di Sario, M. Marzioni, et al.
Leptin Enhances Cholangiocarcinoma Cell Growth
Cancer Res., August 15, 2008; 68(16): 6752 - 6761.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.